Préparation de la matrice de séquençage (amplification clonale) ,
Incidence des cancers de la thyroïde à partir des données des registres du cancer : description sur la période, 1982. ,
Unbiased estimates of long-term net survival of solid cancers in France, International Journal of Cancer, vol.49, issue.10, pp.2370-2377, 2013. ,
DOI : 10.1002/ijc.27857
Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach, The American Journal of Surgical Pathology, vol.31, issue.8, pp.1256-1264, 2007. ,
DOI : 10.1097/PAS.0b013e3180309e6a
Thyroid carcinoma, The Lancet, vol.361, issue.9356, pp.501-511, 2003. ,
DOI : 10.1016/S0140-6736(03)12488-9
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer, Thyroid, vol.22, issue.11, pp.1104-1139, 2012. ,
DOI : 10.1089/thy.2012.0302
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, JAMA, vol.295, issue.18, pp.2164-2167, 1973. ,
DOI : 10.1001/jama.295.18.2164
Anaplastic Thyroid Carcinoma, Frontiers in Endocrinology, vol.3, p.84, 2012. ,
DOI : 10.3389/fendo.2012.00084
Risk Factors for Anaplastic Thyroid Cancer, International Journal of Endocrinology, vol.114, issue.1, p.815070, 2014. ,
DOI : 10.1067/msy.2001.118266
Anaplastic thyroid carcinoma, Cancer, vol.70, issue.Suppl 2, pp.1330-1335, 2005. ,
DOI : 10.1002/cncr.20936
Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996, Cancer, vol.7, issue.1, pp.202-217, 2000. ,
DOI : 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A
Histologic trends in thyroid cancer 1969???1993: A clinico-pathologic analysis of the relative proportion of anaplastic carcinoma of the thyroid, Journal of Surgical Oncology, vol.65, issue.4, pp.251-255, 1996. ,
DOI : 10.1002/(SICI)1096-9098(199612)63:4<251::AID-JSO7>3.0.CO;2-B
Anaplastic (sarcomatoid) carcinoma of the thyroid gland, Semin. Diagn. Pathol, vol.10, pp.159-168, 1993. ,
Trend in Thyroid Carcinoma Size, Age at Diagnosis, and Histology in a Retrospective Study of 500 Cases Diagnosed Over 20 Years, Thyroid, vol.16, issue.11, pp.1151-1155, 2006. ,
DOI : 10.1089/thy.2006.16.1151
Anaplastic (undifferentiated) thyroid carcinoma (ATC), Langenbeck's Archives of Surgery, vol.384, issue.3, pp.284-293, 1999. ,
DOI : 10.1007/s004230050205
Changing patterns of thyroid carcinoma. Ir, J. Med. Sci, vol.176, pp.87-90, 2007. ,
The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma, Cancer, vol.9, issue.6, pp.1146-1153, 1998. ,
DOI : 10.1002/(SICI)1097-0142(19980315)82:6<1146::AID-CNCR20>3.0.CO;2-5
Lower Incidence of Anaplastic Carcinoma After Higher Iodination of Salt in Slovenia, Thyroid, vol.20, issue.6, pp.623-626, 2010. ,
DOI : 10.1089/thy.2009.0404
Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.15, pp.43-48, 1989. ,
Anaplastic thyroid carcinoma: A 50-year experience at a single institution, Surgery, vol.130, issue.6, pp.1028-1034, 2001. ,
DOI : 10.1067/msy.2001.118266
Anaplastic Thyroid Carcinoma: Association With Differentiated Thyroid Cancer, Archives of Otolaryngology - Head and Neck Surgery, vol.114, issue.1, pp.40-44, 1988. ,
DOI : 10.1001/archotol.1988.01860130044012
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U, S, vol.83, pp.2638-2648, 1985. ,
Cardiac metastasis from primary anaplastic thyroid carcinoma: report of three cases and a review of the literature, Endocrine Related Cancer, vol.8, issue.1, pp.71-73, 2001. ,
DOI : 10.1677/erc.0.0080071
Enseignement Post-Universitaire -Prise en charge pratique et diagnostique des prélèvements thyroïdiens : cytoponctions, extemporanés ,
Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases, Cancer, vol.7, issue.2, pp.321-330, 1990. ,
DOI : 10.1002/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A
Anaplastic Thyroid Carcinoma: A Study of 70 Cases, American Journal of Clinical Pathology, vol.83, issue.2, pp.135-158, 1985. ,
DOI : 10.1093/ajcp/83.2.135
Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer, International Journal of Endocrinology, vol.70, issue.1, p.790834, 2014. ,
DOI : 10.1089/thy.2011.0258
Paucicellular Variant of Anaplastic Thyroid Carcinoma: Report of Two Cases, Endocrine Pathology, vol.12, issue.2, pp.157-161, 2001. ,
DOI : 10.1385/EP:12:2:157
Anaplastic Thyroid Carcinoma with Osteoclast-like Giant Cells, The American Journal of Surgical Pathology, vol.15, issue.2, pp.160-168, 1991. ,
DOI : 10.1097/00000478-199102000-00009
Anaplastic thyroid carcinoma with rhabdoid features, Diagnostic Cytopathology, vol.7, issue.5, pp.416-420, 2015. ,
DOI : 10.1002/dc.23254
Anaplastic Thyroid Carcinoma with Rhabdomyoblastic Differentiation: A Case Report with a Good Clinical Outcome, Endocrine Pathology, vol.202, issue.1, pp.62-65, 2008. ,
DOI : 10.1007/s12022-008-9017-3
Rhabdoid tumor of the thyroid gland: a variant of anaplastic carcinoma, Arch. Pathol. Lab. Med, vol.129, pp.55-57, 2005. ,
Lymphoepithelioma-like anaplastic thyroid carcinoma: Report of a case not related to Epstein-Barr virus, Annals of Diagnostic Pathology, vol.5, issue.1, pp.21-24, 2001. ,
DOI : 10.1053/adpa.2001.21480
Undifferentiated thyroid tumors of diffuse small cell type, Virchows Archiv A Pathological Anatomy and Histopathology, vol.10, issue.2, pp.117-126, 1984. ,
DOI : 10.1007/BF00704057
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies, Clinical Oncology, vol.22, issue.6, pp.486-497, 2010. ,
DOI : 10.1016/j.clon.2010.03.013
Molecular pathogenesis and mechanisms of thyroid cancer, Nature Reviews Cancer, vol.57, issue.3, pp.184-199, 2013. ,
DOI : 10.1038/nrc3431
Pathogenetic mechanisms in thyroid follicular-cell neoplasia, Nature Reviews Cancer, vol.88, issue.4, pp.292-306, 2006. ,
DOI : 10.1038/nrc1836
Recent Advances in Molecular Biology of Thyroid Cancer and Their Clinical Implications, Otolaryngologic Clinics of North America, vol.41, issue.6, pp.1135-1146, 2008. ,
DOI : 10.1016/j.otc.2008.07.001
Anaplastic Thyroid Cancers Harbor Novel Oncogenic Mutations of the ALK Gene, Cancer Research, vol.71, issue.13, pp.4403-4411, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-4041
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome, Nature Genetics, vol.57, issue.1, pp.64-67, 1997. ,
DOI : 10.1001/jama.276.19.1575
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer, Journal of Medical Genetics, vol.41, issue.3, pp.161-170, 2004. ,
DOI : 10.1136/jmg.2003.015339
Overexpression and overactivation of Akt in thyroid carcinoma, Cancer Res, vol.61, pp.6105-6111, 2001. ,
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1, Cancer Research, vol.69, issue.11, pp.4885-4893, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0727
Multiple Signaling Pathways Converge on ??-Catenin in Thyroid Cancer, Thyroid, vol.15, issue.6, pp.551-561, 2005. ,
DOI : 10.1089/thy.2005.15.551
Expression of hypoxia-inducible factor 1?? in thyroid carcinomas, Endocrine Related Cancer, vol.17, issue.1, pp.61-72, 2010. ,
DOI : 10.1677/ERC-08-0251
GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1?? (HIF-1??) Pathways, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.12, pp.1934-1943, 2011. ,
DOI : 10.1210/jc.2011-1426
PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer, Oncogene, vol.27, issue.4, pp.509-517, 2009. ,
DOI : 10.1093/carcin/bgg111
NF-??B as a Critical Link Between Inflammation and Cancer, Cold Spring Harbor Perspectives in Biology, vol.1, issue.5, p.141, 2009. ,
DOI : 10.1101/cshperspect.a000141
Role of NF-??B in thyroid cancer, Molecular and Cellular Endocrinology, vol.321, issue.1, pp.29-35, 2010. ,
DOI : 10.1016/j.mce.2009.10.010
The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers, Thyroid, vol.23, issue.2, pp.209-218, 2013. ,
DOI : 10.1089/thy.2012.0237
Promotes Invasiveness of Thyroid Cancer Cells through Nuclear Factor ??B Activation, Endocrinology, vol.147, issue.12, pp.5699-5707, 2006. ,
DOI : 10.1210/en.2006-0400
Potent Inhibition of Thyroid Cancer Cells by the MEK Inhibitor PD0325901 and Its Potentiation by Suppression of the PI3K and NF-??B Pathways, Thyroid, vol.18, issue.8, pp.853-864, 2008. ,
DOI : 10.1089/thy.2007.0357
Wnt/??-Catenin Signaling and Disease, Cell, vol.149, issue.6, pp.1192-1205, 2012. ,
DOI : 10.1016/j.cell.2012.05.012
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma, Cancer Res, vol.59, pp.1811-1815, 1999. ,
??-Catenin Dysregulation in Thyroid Neoplasms, The American Journal of Pathology, vol.158, issue.3, pp.987-996, 2001. ,
DOI : 10.1016/S0002-9440(10)64045-X
Immunophenotyping of thyroid tumors identifies molecular markers altered during transformation of differentiated into anaplastic carcinoma, The American Journal of Surgery, vol.201, issue.5, pp.580-586, 2011. ,
DOI : 10.1016/j.amjsurg.2011.01.010
Role of the Wnt Pathway in Thyroid Cancer, Frontiers in Endocrinology, vol.3, p.31, 2012. ,
DOI : 10.3389/fendo.2012.00031
Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma, Oncogene, vol.63, issue.16, pp.2007-2016, 2012. ,
DOI : 10.1038/sj.onc.1210680
The ??-Catenin Axis Integrates Multiple Signals Downstream from RET/Papillary Thyroid Carcinoma Leading to Cell Proliferation, Cancer Research, vol.69, issue.5, pp.1867-1876, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-1982
Molecular mechanisms of epithelial???mesenchymal transition, Nature Reviews Molecular Cell Biology, vol.22, issue.3, pp.178-196, 2014. ,
DOI : 10.1038/nrm3758
Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid Tumorigenesis, Cancer Research, vol.64, issue.5, pp.1664-1668, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-3242
Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1(HIF-1) in tumour cells in papillary carcinoma of the thyroid, The Journal of Pathology, vol.202, issue.3, pp.352-358, 2004. ,
DOI : 10.1002/path.1522
Two G protein oncogenes in human endocrine tumors, Science, vol.249, issue.4969, pp.655-659, 1990. ,
DOI : 10.1126/science.2116665
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid
adenomas, Nature, vol.365, issue.6447, pp.649-651, 1993. ,
DOI : 10.1038/365649a0
Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas, British Journal of Cancer, vol.90, issue.2, pp.492-496, 2004. ,
DOI : 10.1038/sj.bjc.6601530
Genome-Wide Appraisal of Thyroid Cancer Progression, The American Journal of Pathology, vol.161, issue.5, pp.1549-1556, 2002. ,
DOI : 10.1016/S0002-9440(10)64433-1
DNA Copy Number Changes in Thyroid Carcinoma, The American Journal of Pathology, vol.154, issue.5, pp.1539-1547, 1999. ,
DOI : 10.1016/S0002-9440(10)65407-7
Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, Genes. Chromosomes Cancer, vol.17, issue.27, pp.19-22, 2000. ,
Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.8, pp.3106-3116, 2008. ,
DOI : 10.1210/jc.2008-0273
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells, Molecular Carcinogenesis, vol.84, issue.2, pp.98-107, 2004. ,
DOI : 10.1002/mc.20042
The role of the PAX8/PPAR?? fusion oncogene in the pathogenesis of follicular thyroid cancer, Molecular and Cellular Endocrinology, vol.321, issue.1, pp.50-56, 2010. ,
DOI : 10.1016/j.mce.2009.10.013
CpG Island Methylation of Tumor-Related Promoters Occurs Preferentially in Undifferentiated Carcinoma, Thyroid, vol.16, issue.7, pp.633-642, 2006. ,
DOI : 10.1089/thy.2006.16.633
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas, Oncogene, vol.91, issue.54, pp.7590-7595, 2007. ,
DOI : 10.1038/sj.onc.1210564
Thyroid cell transformation requires the expression of the HMGA1 proteins, Oncogene, vol.21, issue.19, pp.2971-2980, 2002. ,
DOI : 10.1038/sj.onc.1205368
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines, Cancer Science, vol.2, issue.2, pp.280-286, 2008. ,
DOI : 10.1038/ncb985
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells, Cancer Science, vol.88, issue.6, pp.1147-1154, 2008. ,
DOI : 10.1111/j.1349-7006.2008.00800.x
gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors, Cancer, vol.90, issue.9, pp.2440-2447, 2008. ,
DOI : 10.1002/cncr.23869
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry, Blood, vol.84, pp.3648-3652, 1994. ,
Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma, Science, vol.263, issue.5151, pp.316-317, 1995. ,
DOI : 10.1126/science.8122112
ALK-immunoreactive neoplasms, Int. J. Clin. Exp. Pathol, vol.5, pp.397-410, 2012. ,
RET/PTC Rearrangements Preferentially Occurred in Papillary Thyroid Cancer among Atomic Bomb Survivors Exposed to High Radiation Dose, Cancer Research, vol.68, issue.17, pp.7176-7182, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-0293
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase???Rearranged Anaplastic Thyroid Carcinoma, Journal of Clinical Oncology, vol.33, issue.20, 2014. ,
DOI : 10.1200/JCO.2013.49.6596
Identification of a Recurrent STRN/ALK Fusion in Thyroid Carcinomas, PLoS ONE, vol.8, issue.1, p.87170, 2014. ,
DOI : 10.1371/journal.pone.0087170.s003
Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system, Oncogene, vol.14, issue.4, pp.439-449, 1997. ,
DOI : 10.1038/sj.onc.1200849
The anaplastic lymphoma kinase in the pathogenesis of cancer, Nature Reviews Cancer, vol.159, issue.1, pp.11-23, 2008. ,
DOI : 10.1002/ijc.21490
Anaplastic Lymphoma Kinase Inhibition in Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.363, issue.18, pp.1693-1703, 2010. ,
DOI : 10.1056/NEJMoa1006448
ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor, Modern Pathology, vol.14, issue.6, pp.569-576, 2001. ,
DOI : 10.1038/modpathol.3880352
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival, Cancer, vol.83, issue.12, pp.2335-2342, 2001. ,
DOI : 10.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.0.CO;2-1
Anaplastic carcinoma of the thyroid, The American Journal of Surgery, vol.177, issue.4, pp.337-339, 1999. ,
DOI : 10.1016/S0002-9610(99)00052-5
Prognostic Factors and Therapeutic Strategy for Anaplastic Carcinoma of the Thyroid, World Journal of Surgery, vol.25, issue.5, pp.617-622, 2001. ,
DOI : 10.1007/s002680020166
Anaplastic Thyroid Carcinoma Survival, World Journal of Surgery, vol.23, issue.9, pp.975-978, 1999. ,
DOI : 10.1007/s002689900610
Epidemiology, clinical presentation, treatment and prognosis of a regional series of 26 anaplastic thyroid carcinomas (ATC). Comparison with the literature, Annales d'Endocrinologie, vol.71, issue.1, pp.38-45, 2010. ,
DOI : 10.1016/j.ando.2009.10.013
Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma, American Journal of Clinical Oncology, vol.31, issue.5, pp.460-464, 2008. ,
DOI : 10.1097/COC.0b013e31816a61f3
Prognostic factors for thyroid carcinoma, Cancer, vol.64, issue.3, pp.564-573, 1997. ,
DOI : 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0
Anaplastic carcinoma of the thyroid: A 24-year experience, Head & Neck, vol.24, issue.1, pp.41-47, 1995. ,
DOI : 10.1002/hed.2880170109
Approach to the Patient with Anaplastic Thyroid Carcinoma, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.8, pp.2566-2572, 2012. ,
DOI : 10.1210/jc.2012-1314
Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment, Journal of Oncology, vol.167, issue.6, p.542358, 2011. ,
DOI : 10.1089/thy.2008.0281
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery, British Journal of Cancer, vol.20, issue.12, pp.1848-1853, 2002. ,
DOI : 10.1016/S0304-3835(97)04742-3
Hyperfractionated Accelerated Radiotherapy (HART) for Anaplastic Thyroid Carcinoma: Toxicity and Survival Analysis, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.2, pp.518-521, 2009. ,
DOI : 10.1016/j.ijrobp.2008.08.016
Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma, Radiotherapy and Oncology, vol.20, issue.1, pp.3-9, 1991. ,
DOI : 10.1016/0167-8140(91)90105-P
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy, Head & Neck, vol.62, pp.829-836, 2010. ,
DOI : 10.1002/hed.21257
Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland, Radiotherapy and Oncology, vol.60, issue.2, pp.173-180, 2001. ,
DOI : 10.1016/S0167-8140(01)00382-6
Update on thyroid cancer treatment, Future Oncology, vol.8, issue.10, pp.1331-1348, 2012. ,
DOI : 10.2217/fon.12.123
Phase II Trial of Sorafenib in Advanced Thyroid Cancer, Journal of Clinical Oncology, vol.26, issue.29, pp.4714-4719, 2008. ,
DOI : 10.1200/JCO.2008.16.3279
Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice, Molecular Cancer Therapeutics, vol.6, issue.6, pp.1785-1792, 2007. ,
DOI : 10.1158/1535-7163.MCT-06-0595
Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study, The Lancet Oncology, vol.10, issue.8, pp.794-800, 2009. ,
DOI : 10.1016/S1470-2045(09)70171-8
A significant response to sunitinib in a patient with anaplastic thyroid carcinoma, J. Res. Med. Sci. Off. J. Isfahan Univ. Med. Sci, vol.18, pp.623-625, 2013. ,
Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case report, Anticancer Res, vol.32, pp.1743-1746, 2012. ,
A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.9, pp.3179-3184, 2012. ,
DOI : 10.1210/jc.2012-1520
Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study, Journal of Clinical Oncology, vol.26, issue.29, pp.4708-4713, 2008. ,
DOI : 10.1200/JCO.2007.15.9566
BRAF V600E Inhibition in Anaplastic Thyroid Cancer, New England Journal of Medicine, vol.368, issue.7, pp.684-685, 2013. ,
DOI : 10.1056/NEJMc1215697
A Phase II Study of Imatinib in Patients with Advanced Anaplastic Thyroid Cancer, Thyroid, vol.20, issue.9, pp.975-980, 2010. ,
DOI : 10.1089/thy.2010.0057
Good Clinical Response to Erlotinib in a Patient With Anaplastic Thyroid Carcinoma Harboring an Epidermal Growth Factor Somatic Mutation, L858R, in Exon 21, Journal of Clinical Oncology, vol.29, issue.16, pp.465-467, 2011. ,
DOI : 10.1200/JCO.2010.34.0216
Oncocytic, focally anaplastic, thyroid cancer responding to erlotinib, Journal of Oncology Pharmacy Practice, vol.31, issue.8, pp.111-117, 2009. ,
DOI : 10.1177/1078155208101212
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer, Thyroid, vol.18, issue.3, pp.317-323, 2008. ,
DOI : 10.1089/thy.2007.0120
A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome, Thyroid, vol.19, issue.3, pp.233-240, 2009. ,
DOI : 10.1089/thy.2008.0321
) Gene in Adult-Onset Papillary Thyroid Cancer Amongst Atomic Bomb Survivors, Thyroid, vol.22, issue.11, pp.1153-1159, 2012. ,
DOI : 10.1089/thy.2011.0511
Whole-genome Sequencing of an Aggressive BRAF Wild-type Papillary Thyroid Cancer Identified EML4???ALK Translocation as a Therapeutic Target, World Journal of Surgery, vol.40, issue.14, pp.1296-1305, 2014. ,
DOI : 10.1007/s00268-014-2485-3
Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer, Proceedings of the National Academy of Sciences, vol.111, issue.11, pp.4233-4238, 2014. ,
DOI : 10.1073/pnas.1321937111
Impact of deleterious passenger mutations on cancer progression, Proceedings of the National Academy of Sciences, vol.110, issue.8, pp.2910-2915, 2013. ,
DOI : 10.1073/pnas.1213968110
Pitfalls in Lung Cancer Molecular Pathology: How to Limit them in Routine Practice?, Current Medicinal Chemistry, vol.19, issue.16, pp.2638-2651, 2012. ,
DOI : 10.2174/092986712800493002
Next-generation sequencing for lung cancer, Future Oncology, vol.9, issue.9, pp.1323-1336, 2013. ,
DOI : 10.2217/fon.13.102
Tissue microarrays for high-throughput molecular profiling of tumor specimens, Nature Medicine, vol.54, issue.7, pp.844-847, 1998. ,
DOI : 10.1023/A:1005769925670
Tissue microarrays (TMAs) for high-throughput molecular pathology research, International Journal of Cancer, vol.65, issue.1, pp.1-5, 2001. ,
DOI : 10.1002/ijc.1385
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH, Journal of Thoracic Oncology, vol.6, issue.3, pp.459-465, 2011. ,
DOI : 10.1097/JTO.0b013e318209edb9
A testing algorithm for detection of the B-type Raf kinase V600E mutation in papillary thyroid carcinoma, Human Pathology, vol.45, issue.7, pp.1483-1488, 2014. ,
DOI : 10.1016/j.humpath.2014.02.025
Tissue Microarray Cytometry Reveals Positive Impact of Homeodomain Interacting Protein Kinase 2 in Colon Cancer Survival Irrespective of p53 Function, The American Journal of Pathology, vol.178, issue.5, pp.1986-1998, 2011. ,
DOI : 10.1016/j.ajpath.2011.01.021
Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non???Small-Cell Lung Cancer, Clinical Lung Cancer, vol.13, issue.6, pp.500-504, 2012. ,
DOI : 10.1016/j.cllc.2012.05.009
PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma, British Journal of Cancer, vol.18, issue.12, pp.1938-1943, 2015. ,
DOI : 10.1002/cncr.11175
Survol de la technologie de séquençage PGM Ion Torrent ,
A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma, The American Journal of Surgical Pathology, vol.39, issue.5, pp.652-659, 2015. ,
DOI : 10.1097/PAS.0000000000000368
Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications, Endocrine Reviews, vol.28, issue.7, pp.742-762, 2007. ,
DOI : 10.1210/er.2007-0007
BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.12, pp.6373-6379, 2005. ,
DOI : 10.1210/jc.2005-0987
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation, Journal of Clinical Investigation, vol.121, issue.12, pp.4700-4711, 2011. ,
DOI : 10.1172/JCI46382DS1
Mutationally Activated BRAFV600E Elicits Papillary Thyroid Cancer in the Adult Mouse, Cancer Research, vol.71, issue.11, pp.3863-3871, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-4463
Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation, Cancer Research, vol.65, issue.10, pp.4238-4245, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0047
Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.11, pp.5399-5404, 2003. ,
DOI : 10.1210/jc.2003-030838
Conditional BRAFV600E Expression Induces DNA Synthesis, Apoptosis, Dedifferentiation, and Chromosomal Instability in Thyroid PCCL3 Cells, Cancer Research, vol.65, issue.6, pp.2465-2473, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-3314
BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment, Modern Pathology, vol.4, issue.11, pp.1359-1363, 2004. ,
DOI : 10.1038/modpathol.3800198
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions, Molecular and Cellular Endocrinology, vol.322, issue.1-2, pp.8-28, 2010. ,
DOI : 10.1016/j.mce.2010.01.007
Detection of activated ras oncogenes in human thyroid carcinomas, Oncogene, vol.2, pp.403-406, 1988. ,
Activated ras oncogenes in human thyroid cancers, Cancer Res, vol.48, pp.4459-4463, 1988. ,
Thyroid carcinoma: molecular pathways and therapeutic targets, Modern Pathology, vol.98, pp.37-43, 2008. ,
DOI : 10.1038/nature04304
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673022
Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation, Oncogene, vol.19, issue.7, pp.924-932, 2000. ,
DOI : 10.1038/sj.onc.1203393
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma, Oncogene, vol.4, pp.1457-1462, 1989. ,
The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors, Molecular and Cellular Endocrinology, vol.321, issue.1, pp.20-28, 2010. ,
DOI : 10.1016/j.mce.2009.10.016
Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.1, pp.278-284, 2008. ,
DOI : 10.1210/jc.2007-1076
Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing, Human Molecular Genetics, vol.24, issue.8, pp.2318-2329, 2015. ,
DOI : 10.1093/hmg/ddu749
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas., Journal of Clinical Investigation, vol.91, issue.1, pp.179-184, 1993. ,
DOI : 10.1172/JCI116168
Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland., Journal of Clinical Investigation, vol.91, issue.4, pp.1753-1760, 1993. ,
DOI : 10.1172/JCI116385
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer, Proceedings of the National Academy of Sciences, vol.111, issue.16, pp.1600-1609, 2014. ,
DOI : 10.1073/pnas.1404357111
Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.3, pp.497-507, 2014. ,
DOI : 10.1210/jc.2013-1512
p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells, Oncogene, vol.14, issue.6, pp.729-740, 1997. ,
DOI : 10.1038/sj.onc.1200887
Effects of p53-Expressing Adenovirus on the Chemosensitivity and Differentiation of Anaplastic Thyroid Cancer Cells, The Journal of Clinical Endocrinology & Metabolism, vol.83, issue.7, pp.2516-2522, 1998. ,
DOI : 10.1210/jcem.83.7.4984
Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer, Clinical Cancer Research, vol.13, issue.4, pp.1161-1170, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-1125
Tumor Suppressor Pathway, Journal of Clinical Oncology, vol.22, issue.14, pp.2954-2963, 2004. ,
DOI : 10.1200/JCO.2004.02.141
Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors, Oncotarget, vol.2, issue.12, pp.1109-1126, 2011. ,
DOI : 10.18632/oncotarget.380
Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms, J. Clin. Endocrinol. Metab, vol.79, pp.1317-1321, 1994. ,
HER2 expression in thyroid tumors, Am. Surg, vol.69, pp.1100-1103, 2003. ,
Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease, Virchows Arch. Int. J. Pathol, vol.442, pp.322-328, 2003. ,
Expression of c-erbB-2 oncoprotein in human thyroid tumours, Histopathology, vol.30, issue.1, pp.60-65, 1999. ,
DOI : 10.1038/328170a0
Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification, Human Pathology, vol.39, issue.1, pp.15-20, 2008. ,
DOI : 10.1016/j.humpath.2007.05.012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2, Proceedings of the National Academy of Sciences, vol.109, issue.36, pp.14476-14481, 2012. ,
DOI : 10.1073/pnas.1203201109
Non-Small-Cell Lung Cancer and Ba/F3 Transformed Cells Harboring the ERBB2 G776insV_G/C Mutation Are Sensitive to the Dual-Specific Epidermal Growth Factor Receptor and ERBB2 Inhibitor HKI-272, Cancer Research, vol.66, issue.13, pp.6487-6491, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-0971
Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib, PLoS ONE, vol.6, issue.10, p.26760, 2011. ,
DOI : 10.1371/journal.pone.0026760.s007
Exons 12 and 15 in Sporadic Medullary Thyroid Carcinomas: Different Spectrum of Mutations in Sporadic Type from Hereditary Type, Japanese Journal of Cancer Research, vol.18, issue.11, pp.1231-1237, 1999. ,
DOI : 10.1111/j.1349-7006.1999.tb00701.x
RET tyrosine kinase signaling in development and cancer, Cytokine & Growth Factor Reviews, vol.16, issue.4-5, pp.441-467, 2005. ,
DOI : 10.1016/j.cytogfr.2005.05.010
Genetic basis of endocrine disease: multiple endocrine neoplasia type 2, J. Clin. Endocrinol. Metab, vol.80, pp.1989-1995, 1995. ,
A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours, Oncogene, vol.159, issue.34, pp.5344-5354, 2005. ,
DOI : 10.1038/sj.onc.1202866
TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature, vol.390, issue.6659, pp.465-471, 1997. ,
DOI : 10.1038/37284
Hypermethylation of the CDKN2/p16INK4A Promotor in Thyroid Carcinogenesis, Pathology - Research and Practice, vol.199, issue.6, pp.399-404, 2003. ,
DOI : 10.1078/0344-0338-00436
Infrequent CDKN2 mutation in human differentiated thyroid cancers, Molecular Carcinogenesis, vol.15, issue.1, pp.5-10, 1996. ,
DOI : 10.1002/(SICI)1098-2744(199601)15:1<5::AID-MC2>3.3.CO;2-9
Status and expression of the p16INK4 gene in human thyroid tumors and thyroid???tumor cell lines, International Journal of Cancer, vol.67, issue.1, pp.29-34, 1996. ,
DOI : 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.3.CO;2-P
The ATM-mediated DNA-damage response: taking shape, Trends in Biochemical Sciences, vol.31, issue.7, pp.402-410, 2006. ,
DOI : 10.1016/j.tibs.2006.05.004
ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility, Journal of Mammary Gland Biology and Neoplasia, vol.9, issue.3, pp.247-262, 2004. ,
DOI : 10.1023/B:JOMG.0000048772.92326.a1
Sporadic ret???rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?, The Journal of Pathology, vol.185, issue.1, pp.71-78, 1998. ,
DOI : 10.1002/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.3.CO;2-J
PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.4, pp.287-294, 1998. ,
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.11, pp.1852-1860, 2013. ,
DOI : 10.1210/jc.2013-2292
A Central Role for RAF???MEK???ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma, Cancer Discovery, vol.2, issue.8, pp.685-693, 2012. ,
DOI : 10.1158/2159-8290.CD-11-0347
Fetal cell carcinogenesis of the thyroid: A modified theory based on recent evidence [My Opinion], Endocrine Journal, vol.61, issue.4, pp.311-320, 2014. ,
DOI : 10.1507/endocrj.EJ13-0517
Test de la sonde commerciale RET ZYTOVISION sur des carcinomes papillaires de la thyroïde avec le kit ZYTOVISION ,